Bupropion Hydrochloride
Product Images NDC 66336-897

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 66336-897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

9a504cce-figure-01 (9a504cce Figure 01)

FDA Label Image

Ndc 66336-0897-xx (Ndc 66336 0897 Xx Catalent Pharma Solutions)

Ndc 66336-0897-xx (Ndc 66336 0897 Xx      Catalent Pharma Solutions)
This is a description of a drug product manufactured by Catalent Pharma Solutions in Winchester, KY. It is a pale yellow, round, biconvex film-coated tablet with "A 133" debossed on it. The product code 753-XX identifies each extended-release tablet containing Bupropion Hydrochloride USP 150mg. The product should not be used in combination with e2YBAN or other drugs that contain it, and alcohol should be avoided. The tablet should be dispensed with medication guide and stored at 68-77°F in a light-resistant container. The drug is not available for children and is packed exclusively by Dispensing Solutions in Santa Ana, CA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.